A lower dosage of imatinib in patients with gastrointestinal stromal tumors with toxicity of the treatment

被引：0
|
作者：
Yin, Y. [1 ]
Tang, S. [2 ]
Shen, C. [1 ]
Zhang, B. [2 ]
机构：
[1] West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-088
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [1] A lower dosage of imatinib in patients with gastrointestinal stromal tumors with toxicity of the treatment
    Yin, Yuan
    Xiang, Jin
    Tang, Sumin
    Chen, Jiaju
    Yu, Qin
    Zhang, Bo
    MEDICINE, 2016, 95 (49) : e5488
  • [2] Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors
    Saponara, Maristella
    Gatto, Lidia
    Di Nunno, Vincenzo
    Tabacchi, Elena
    Fanti, Stefano
    Di Scioscio, Valerio
    Nannini, Margherita
    Gruppioni, Elisa
    Altimari, Annalisa
    Fiorentino, Michelangelo
    Santini, Donatella
    Ceccarelli, Claudio
    Zompatori, Maurizio
    Biasco, Guido
    Pantaleo, Maria Abbondanza
    ANTI-CANCER DRUGS, 2016, 27 (04) : 353 - 363
  • [3] Efficacy evaluation of imatinib in the treatment of patients with gastrointestinal stromal tumors
    Zong, Liang
    Chen, Ping
    Zhao, Wei
    Shi, Lei
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2011, 22 (05): : 479 - 485
  • [4] Nonadherence to Imatinib Treatment in Patients with Gastrointestinal Stromal Tumors: The ADAGIO Study
    Mazzeo, Filomena
    Duck, Lionel
    Joosens, Eric
    Dirix, Luc
    Focan, Christian
    Forget, Frederic
    De Geest, Sabina
    Muermans, Katja
    Van Lierde, Marie-Anne
    Macdonald, Karen
    Abraham, Ivo
    De Greve, Jacques
    ANTICANCER RESEARCH, 2011, 31 (04) : 1407 - 1409
  • [5] Impact of pharmacogenomics on imatinib toxicity in gastrointestinal stromal tumors.
    Zhuang, Wei
    Qiu, Haibo
    Wang, Xueding
    Xin, Shuang
    Huang, Min
    Zhou, Zhiwei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Update on imatinib for gastrointestinal stromal tumors: duration of treatment
    Linch, Mark
    Claus, Jeroen
    Benson, Charlotte
    ONCOTARGETS AND THERAPY, 2013, 6 : 1011 - 1023
  • [7] Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors
    Blay, J. -Y.
    Perol, D.
    Le Cesne, A.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1659 - 1665
  • [8] Adherence to imatinib therapy in patients with gastrointestinal stromal tumors
    Blay, Jean-Yves
    Rutkowski, Piotr
    CANCER TREATMENT REVIEWS, 2014, 40 (02) : 242 - 247
  • [9] Neoadjuvant, adjuvant, and palliative treatment with imatinib in patients with gastrointestinal stromal tumors.
    Nilsson, B. E.
    Sjolund, K.
    Nilsson, E. P.
    Wangberg, B.
    Nilsson, O.
    Ahlman, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
    Andtbacka, RH
    Cormier, JN
    Scaife, CL
    Hunt, KK
    Pisters, PW
    Pollock, RE
    Benjamin, RS
    Burgess, MA
    Chen, LL
    Feig, BW
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S35 - S35
12345